Salix Pharmaceuticals Medical Affairs

For over 30 years, Salix Pharmaceuticals, a wholly owned subsidiary of Bausch Health, has licensed, developed and marketed innovative products to treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea, traveler’s diarrhea, opioid-induced constipation and ulcerative colitis, among many others.